These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10424842)

  • 41. Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada.
    O'Brien B; Goeree R; Mohamed AH; Hunt R
    Arch Intern Med; 1995 Oct; 155(18):1958-64. PubMed ID: 7575049
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Anti-Helicobacter pylori therapy. Who should be treated, how, how long?].
    Lux G
    Fortschr Med; 1996 Aug; 114(22-23):273-5. PubMed ID: 8974961
    [No Abstract]   [Full Text] [Related]  

  • 43. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
    Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A
    Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Triple ranitidine therapy in Helicobacter pylori infection. Recommendation for effective, safe and cost effective combination for Helicobacter pylori eradication].
    Miederer S
    Fortschr Med; 1996 Nov; 114(33):460-2. PubMed ID: 9081895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The "stomach evil" Helicobacter pylori: also stomach cancer is usually accredited to Helicobacter pylori].
    MMW Fortschr Med; 2004 Jun; 146(24):54. PubMed ID: 15366502
    [No Abstract]   [Full Text] [Related]  

  • 46. Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance.
    Veldhuyzen van Zanten S; Hunt RH; Cockeram A; Schep G; Malatjalian D; Sidorov J; Matisko A; Jewell D
    Am J Gastroenterol; 1998 Jan; 93(1):5-10. PubMed ID: 9448164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Therapy of Helicobacter pylori infection: current status].
    Wagner S; Gebel M; Manns M
    Z Gastroenterol; 1993; 31(7-8):459-63. PubMed ID: 8379235
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is upper gastrointestinal radiography a cost-effective alternative to a Helicobacter pylori "test and treat" strategy for patients with suspected peptic ulcer disease?
    Rich M; Scheiman JM; Tierney W; Fendrick AM
    Am J Gastroenterol; 2000 Mar; 95(3):651-8. PubMed ID: 10710053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Helicobacter pylori eradication in long-term proton pump inhibitor users is highly cost-effective: economic analysis of the HELPUP trial.
    Mason JM; Raghunath AS; Hungin AP; Jackson W
    Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1297-303. PubMed ID: 18793340
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study.
    Pilotto A; Perri F; Leandro G; Franceschi M;
    Gerontology; 2006; 52(2):99-106. PubMed ID: 16508317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.
    Kyzekova J; Mour J
    Hepatogastroenterology; 1999; 46(27):2048-56. PubMed ID: 10430396
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
    Koskenpato J; Färkkilä M; Sipponen P
    Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Helicobacter pylori eradication reduces platelet count in patients without idiopathic thrombocytopenic purpura.
    Matsukawa Y; Kato K; Hatta Y; Iwamoto M; Mizuno S; Kurihara R; Arakawa Y; Kurosaka H; Hayashi I; Sawada S
    Platelets; 2007 Feb; 18(1):52-5. PubMed ID: 17365854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section.
    Cooper NJ; Sutton AJ; Abrams KR
    Stat Methods Med Res; 2002 Dec; 11(6):491-512. PubMed ID: 12516986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacoeconomics--determination of the cost-effectiveness of Helicobacter pylori eradication.
    Curtiss FR
    J Manag Care Pharm; 2003; 9(5):451-2, 455-6. PubMed ID: 14613444
    [No Abstract]   [Full Text] [Related]  

  • 56. Estimating uncertainty ranges for costs by the bootstrap procedure combined with probabilistic sensitivity analysis.
    Lord J; Asante MA
    Health Econ; 1999 Jun; 8(4):323-33. PubMed ID: 10398525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit.
    McCabe C; Paulden M; Awotwe I; Sutton A; Hall P
    Pharmacoeconomics; 2020 Feb; 38(2):135-141. PubMed ID: 31840216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Computational methods for probabilistic decision trees.
    Clark DE
    Comput Biomed Res; 1997 Feb; 30(1):19-33. PubMed ID: 9134304
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sensitivity Analysis in Sequential Decision Models.
    Chen Q; Ayer T; Chhatwal J
    Med Decis Making; 2017 Feb; 37(2):243-252. PubMed ID: 27681992
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence synthesis, parameter correlation and probabilistic sensitivity analysis.
    Ades AE; Claxton K; Sculpher M
    Health Econ; 2006 Apr; 15(4):373-81. PubMed ID: 16389628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.